German call for positive drug list, after scandals

25 March 2002

The head of Germany's largest trade union, Verdi, Frank Bsirske, hascalled for the rapid introduction of a positive drugs list after the recent spate of drug corruption scandals in the hospital sector (Marketletter March 18).

Health funds should reimburse only drugs backed by a group of experts and included on a positive list, said Mr Bsirske. The German drug market is insufficiently transparent and there is inadequate information about usage, with further education and development in the sector being organized by the industry itself, he noted, adding that a positive list would also be of considerable help to doctors in working out their own prescribing directions.

Anke Martiny of the German anti-corruption organization Transparency International said the view of experts was that the bribery and corruption being uncovered in the hospital sector and elsewhere in the health service was merely the tip of the iceberg. No other sector of the economy operated on such a "self-service" basis as the health service, because it lacked both controls and transparency, she said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight